Use filters to refine the search results.
Results 1-5 of 5
|1-Jun-2015||The next steps in improving the outcomes of advanced ovarian cancer||Openshaw, MR; Fotopoulou, C; Blagden, S; Gabra, H|
|23-Oct-2015||Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer||Bowtell, DD; Boehm, S; Ahmed, AA; Aspuria, P-J; Bast, RC, et al|
|16-Oct-2015||The La-Related Proteins, a Family with Connections to Cancer||Stavraka, C; Blagden, S|
|1-Oct-2015||Dose-finding quantitative F-18-FDG PET imaging study with the oral pan-AKT inhibitor GSK2141795 in patients with gynecologic malignancies||Gungor, H; Saleem, A; Babar, S; Dina, R; El-Bahrawy, MA, et al|
|29-Dec-2015||The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer||Hopkins, TG; Blagden, S; Mura, M; Ghaem-maghami, S; GlaxoSmithKline Services Unlimited, et al|